Parhofer, Klaus G.

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

Kronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M., Lambert, G., Mach, F., et al. (2022) · European Heart Journal

Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cited by 1,449

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

Wiegman, A., Gidding, S. S., Watts, G. F., Chapman, M. J., Ginsberg, H. N., Cuchel, M., Ose, L., Averna, M., Boileau, C., Borén, J., et al. (2015) · European Heart Journal

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 891

Defining high-fat-diet rat models: Metabolic and molecular effects of different fat types

Buettner, R., Parhofer, K. G., Woenckhaus, M., Wrede, C. E., Kunz-Schughart, L. A., Schölmerich, J., & Bollheimer, L. C. (2006) · Journal of Molecular Endocrinology

Diet, Metabolism, and DiseaseFatty Acid Research and Health

Cited by 704

2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

Mach, F., Koskinas, K. C., Roeters van Lennep, J. E., Tokgözoğlu, L., Badimon, L., Baigent, C., Benn, M., Binder, C. J., Catapano, A. L., De Backer, G. G., et al. (2025) · European Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 688

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

Hegele, R. A., Ginsberg, H. N., Chapman, M. J., Nordestgaard, B. G., Kuivenhoven, J. A., Averna, M., Borén, J., Bruckert, E., Catapano, A. L., Descamps, O. S., et al. (2014) · The Lancet Diabetes & Endocrinology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 635

Clinical review on triglycerides

Laufs, U., Parhofer, K. G., Ginsberg, H. N., & Hegele, R. A. (2020) · European Heart Journal

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 544

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia

Parhofer, K. G. (2015) · Diabetes & Metabolism Journal

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

Cited by 458

HDL cholesterol: reappraisal of its clinical relevance

März, W., Kleber, M. E., Scharnagl, H., Speer, T., Zewinger, S., Ritsch, A., Parhofer, K. G., von Eckardstein, A., Landmesser, U., & Laufs, U. (2017) · Clinical Research in Cardiology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 275

Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study

de Pablos‐Velasco, P., Parhofer, K. G., Bradley, C., Eschwège, E., Gönder-Frederick, L., Maheux, P., Wood, I., & Simon, D. (2014) · Clinical Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 218

Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

Hegele, R. A., Borén, J., Ginsberg, H. N., Arca, M., Averna, M., Binder, C. J., Calabresi, L., Chapman, M. J., Cuchel, M., von Eckardstein, A., et al. (2020) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 204

The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes

Fugmann, M., Breier, M., Rottenkolber, M., Banning, F., Ferrari, U., Sacco, V., Grallert, H., Parhofer, K. G., Seissler, J., Clavel, T., et al. (2015) · Scientific Reports

Gut microbiota and healthOral microbiology and periodontitis research

Cited by 131

Diagnostic algorithm for familial chylomicronemia syndrome

Stroes, E., Moulin, P., Parhofer, K. G., Rebours, V., Löhr, J.-M., & Averna, M. (2017) · Atherosclerosis Supplements

Lipid metabolism and disordersLymphatic Disorders and Treatments

Cited by 130

The Diagnosis and Treatment of Hypertriglyceridemia

Parhofer, K. G., & Laufs, U. (2019) · Deutsches Ärzteblatt international

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 110

Cholesterol, essential fatty acids, and suicide

Brunner, J., Parhofer, K. G., Schwandt, P., & Bronisch, T. (2002) · Pharmacopsychiatry

Suicide and Self-Harm StudiesLipoproteins and Cardiovascular Health

Cited by 85

Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)

Krempf, M., Parhofer, K. G., Steg, P. G., Bhatt, D. L., Ohman, E. M., Röther, J., Goto, S., Pasquet, B., & Wilson, P. W. F. (2010) · The American Journal of Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsAcute Ischemic Stroke Management

Cited by 82

Two-year Vascular Hospitalisation Rates and Associated Costs in Patients at Risk of Atherothrombosis in France and Germany: Highest Burden for Peripheral Arterial Disease

Smolderen, K. G., Wang, K., de Pouvourville, G., Brüggenjürgen, B., Röther, J., Zeymer, U., Parhofer, K. G., Steg, P. G., Bhatt, D. L., & Magnuson, E. A. (2012) · European Journal of Vascular and Endovascular Surgery

Peripheral Artery Disease ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 61

Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis

Pusl, T., Denk, G. U., Parhofer, K. G., & Beuers, U. (2006) · Journal of Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 50

Increasing HDL-cholesterol and prevention of atherosclerosis: A critical perspective

Parhofer, K. G. (2015) · Atherosclerosis Supplements

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 50

Differentiating EPA from EPA/DHA in cardiovascular risk reduction

Toth, P. P., Chapman, M. J., Parhofer, K. G., & Nelson, J. R. (2022) · American Heart Journal Plus: Cardiology Research and Practice

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 33

Poor sleep quality is associated with impaired glucose tolerance in women after gestational diabetes

Ferrari, U., Künzel, H., Tröndle, K., Rottenkolber, M., Kohn, D., Fugmann, M., Banning, F., Weise, M., Sacco, V., Hasbargen, U., et al. (2015) · Journal of Psychiatric Research

Gestational Diabetes Research and ManagementSleep and related disorders

Cited by 23

Anti-PCSK 9 antibodies increase the ratios of the brain-specific oxysterol 24S-hydroxycholesterol to cholesterol and to 27-hydroxycholesterol in the serum

Lütjohann, D., Stellaard, F., Bölükbasi, B., Kerksiek, A., Parhofer, K. G., & Laufs, U. (2021) · British Journal of Clinical Pharmacology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 8

Effectiveness and safety of bempedoic acid in routine clinical practice: 1-year follow-up snapshot of the MILOS German cohort

Gouni-Berthold, I., Koskinas, K., Averna, M., Stulnig, T., Vanassche, T., Blackburn, C., Smolnik, R., Soronen, J., Wenz-Poschl, K., Pinto, X., et al. (2023) · European Heart Journal

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 6

Screening for Gestational Diabetes Mellitus and Pregnancy Outcomes: Results from a Multicentric Study in Tajikistan

Pirmatova, D., Dodkhoeva, M., Hasbargen, U., Flemmer, A. W., Abdusamatzoda, Z., Saburova, K., Salieva, N., Radzhabova, S., & Parhofer, K. G. (2022) · Experimental and Clinical Endocrinology & Diabetes

Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 2